Prescription Digital Therapeutics (PDTs)
- Software developed to treat a specific disease
- Prescribed and reimbursed independently, not co-branded with a drug
- May be indicated for use alongside standard of care pharmacotherapy or a drug class generally
Platform
One powerful platform.
Many ways to treat disease.
We are expanding the possibilities of medicine with software as treatments. Our platform-based approach combines scientifically proven therapies with proprietary neuromodulatory mechanisms of action to deliver clinically-meaningful interventions.
Developing engaging andevidence-baseddigital treatments.
What are Prescription Digital Therapeutics?
Our digital therapies combine clinical science with the power of software to create a new way to treat disease.
Software-based interventions delivered as mobile applications
Regulated by FDA and globally as medical devices
Evidence-based treatment claims validated by clinical trials
Prescribed by a licensed healthcare professional (HCP)
Treat disease with digital mechanisms of action
Click Therapeutics develops software both for standalone use as PDTs and combination use as SEDs, each offering unique value.
Software-Enhanced Drugs™ (SEDs)
- Software developed to treat a specific disease and enhance the benefit of a specific drug
- Prescribed and reimbursed as a drug-software combination product, co-branded with a drug
- Indicated for use alongside a specific drug
Platform
A common foundation. For uncommon results.
Backed by over a decade of development, Click’s platform can target any disease, symptom or side effect with an underlying neurological or behavioral component. It can also enhance the value of pharmacotherapy directly by supplementing efficacy, supporting adherence or improving tolerability.
Clinical Science
Our platform is constantly expanding with new digital mechanisms of action for the treatment of disease. We distill scientifically proven therapies into digital formats, develop novel neuromodulatory interventions, and innovate ways to improve upon traditional medications.
The Power of Software
Advanced and proprietary technologies - from digital biomarkers to AI-powered personalization - enable our platform to deliver dynamic, engaging treatments to patients. Equally sophisticated back-end technology is designed to support secure, stable and scalable solutions that patients and providers can rely on.
New Ways to Treat Disease
By combining the best of clinical science and the power of software, we are expanding the possibilities of medicine. Our platform enables the technical and scientific rigor necessary to deliver results consistently, and thus demonstrate evidence of safety and efficacy in robust randomized clinical trials. Backed by all of the required regulatory and quality controls for new therapies, our platform delivers on what is required to advance the standard of care.
A Platform for Success
Our commitment to advancing research allows us to continually refine and expand our platform technologies, ensuring we stay at the forefront of cognitive, behavioral, and neuromodulatory therapeutic innovation and enabling continuous improvement for every product on our platform.
See our platform in action
Request a demoData tell the full story
Read our publicationsProducts on our platform
CT-156
CT-156
Indication
Schizophrenia
Collaborator
Phase
Phase 2: Dev/PilotCT-156
CT-156
Indication
Schizophrenia
Collaborator
Phase
Phase 2: Dev/PilotClick SE™
Click’s platform enables the development of Software-Enhanced Drug™ therapies
Click SE solutions combine software with pharmacotherapy to create software-enhanced drugs, targeting the unique needs of a specific medication to deliver added clinical benefit to patients.
Standards and certifications
Click Therapeutics is committed to delivering safe and effective digital treatments to people with unmet clinical needs, pursuing a culture of quality and continuous improvement and developing software as a medical device that meets applicable regulatory and security requirements.
Collaborations
Redefining treatment innovation through collaborations
Click’s rigorous approach and clinically validated platform enable us to develop products in-house and in collaboration with pharma partners, working together to develop and commercialize these high-impact digital treatments.
These capabilities extend our proprietary digital therapeutics platform and expertise to the development of software-enhanced drug™ therapies that combine software with pharmacotherapy to offer added clinically meaningful benefit to patients.